Epigallocatechin gallate reduces vascular inflammation in db/db mice possibly through an NF-κB-mediated mechanism

Molecular Nutrition and Food Research

Volumn 56, Issue 9, 2012, Pages 1424-1432

  Babu, Pon V Anandh ^a   Si, Hongwei ^a,b   Liu, Dongmin ^a  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^b TENNESSEE STATE UNIVERSITY   (United States)

Author keywords

Diabetes; Endothelial cells; Epigallocatechin gallate; Green tea; Vascular inflammation

Indexed keywords

ANTIOXIDANT; CATECHIN; DRUG DERIVATIVE; EPIGALLOCATECHIN GALLATE; RELA PROTEIN, MOUSE; TRANSCRIPTION FACTOR RELA;

ANIMAL; AORTA; ARTICLE; CELL ADHESION; CELL LINE; CHEMISTRY; DIET SUPPLEMENTATION; DRUG ANTAGONISM; DRUG EFFECT; ENDOTHELIUM CELL; EXPERIMENTAL DIABETES MELLITUS; HUMAN; HYPERGLYCEMIA; INFLAMMATION; MALE; METABOLISM; MONOCYTE; MOUSE; MOUSE STRAIN; TEA;

ANIMALS; ANTIOXIDANTS; AORTA; CATECHIN; CELL ADHESION; CELL LINE; DIABETES MELLITUS, EXPERIMENTAL; DIETARY SUPPLEMENTS; ENDOTHELIAL CELLS; HUMANS; HYPERGLYCEMIA; INFLAMMATION; MALE; MICE; MICE, INBRED STRAINS; MONOCYTES; TEA; TRANSCRIPTION FACTOR RELA;

MUS;

EID: 84865713969     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201200040     Document Type: Article

References (35)

1. Beckman, J. A., Creager, M. A., Libby, P., Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA 2002, 287, 2570-2581.
2. Ross, R., Atherosclerosis-an inflammatory disease. N. Engl. J. Med. 1999, 340, 115-126.
3. Potenza, M. A., Gagliardi, S., Nacci, C., Carratu, M. R. et al., Endothelial dysfunction in diabetes: from mechanisms to therapeutic targets. Curr. Med. Chem. 2009, 16, 94-112.
4. Srinivasan, S., Bolick, D. T., Hatley, M. E., Natarajan, R. et al., Glucose regulates interleukin-8 production in aortic endothelial cells through activation of the p38 mitogen-activated protein kinase pathway in diabetes. J. Biol. Chem. 2004, 279, 31930-31936.
5. Kunt, T., Forst, T., Fruh, B., Flohr, T. et al., Binding of monocytes from normolipidemic hyperglycemic patients with type 1 diabetes to endothelial cells is increased in vitro. Exp. Clin. Endocrinol. Diabetes 1999, 107, 252-256.
6. Morigi, M., Angioletti, S., Imberti, B., Donadelli, R. et al., Leukocyte-endothelial interaction is augmented by high glucose concentrations and hyperglycemia in a NF-kB-dependent fashion. J. Clin. Invest. 1998, 101, 1905-1915.
7. Srinivasan, S., Yeh, M., Danziger, E. C., Hatley, M. E. et al., Glucose regulates monocyte adhesion through endothelial production of interleukin-8. Circ. Res. 2003, 92, 371-377.
8. Savoia, C., Schiffrin, E. L., Vascular inflammation in hypertension and diabetes: molecular mechanisms and therapeutic interventions. Clin. Sci. (Lond) 2007, 112, 375-384.
9. Yerneni, K. K., Bai, W., Khan, B. V., Medford, R. M. et al., Hyperglycemia-induced activation of nuclear transcription factor kappaB in vascular smooth muscle cells. Diabetes 1999, 48, 855-864.
10. Potenza, M. A., Marasciulo, F. L., Tarquinio, M., Tiravanti, E. et al., EGCG, a green tea polyphenol, improves endothelial function and insulin sensitivity, reduces blood pressure, and protects against myocardial I/R injury in SHR. Am. J. Physiol. Endocrinol. Metab. 2007, 292, E1378-E1387.
11. Wolfram, S., Effects of green tea and EGCG on cardiovascular and metabolic health. J. Am. Coll. Nutr. 2007, 26, 373S-388S.
12. Widlansky, M. E., Hamburg, N. M., Anter, E., Holbrook, M. et al., Acute EGCG supplementation reverses endothelial dysfunction in patients with coronary artery disease. J. Am. Coll. Nutr. 2007, 26, 95-102.
13. Babu, P. V., Liu, D., Green tea catechins and cardiovascular health: an update. Curr. Med. Chem. 2008, 15, 1840-1850.
14. Lambert, J. D., Lee, M. J., Diamond, L., Ju, J. et al., Dose-dependent levels of epigallocatechin-3-gallate in human colon cancer cells and mouse plasma and tissues. Drug Metab. Dispos. 2006, 34, 8-11.
15. Rajesh, M., Mukhopadhyay, P., Batkai, S., Hasko, G. et al., Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption. Am. J. Physiol. Heart Circ. Physiol. 2007, 293, H610-H619.
16. Bose, M., Lambert, J. D., Ju, J., Reuhl, K. R. et al., The major green tea polyphenol, (-)-epigallocatechin-3-gallate, inhibits obesity, metabolic syndrome, and fatty liver disease in high-fat-fed mice. J. Nutr. 2008, 138, 1677-1683.
17. Si, H., Liu, D., Genistein, a soy phytoestrogen, upregulates the expression of human endothelial nitric oxide synthase and lowers blood pressure in spontaneously hypertensive rats. J. Nutr. 2008, 138, 297-304.
18. Srinivasan, S., Hatley, M. E., Reilly, K. B., Danziger, E. C. et al., Modulation of PPARalpha expression and inflammatory interleukin-6 production by chronic glucose increases monocyte/endothelial adhesion. Arterioscler. Thromb. Vasc. Biol. 2004, 24, 851-857.
19. Nishiyama, T., Mishima, K., Ide, F., Yamada, K. et al., Functional analysis of an established mouse vascular endothelial cell line. J. Vascul. Res. 2007, 44, 138-148.
20. de Lemos, J. A., Morrow, D. A., Sabatine, M. S., Murphy, S. A. et al., Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes. Circulation 2003, 107, 690-695.
21. Pittet, M. J., Swirski, F. K., Monocytes link atherosclerosis and cancer. Eur. J. Immunol. 2011, 41, 2519-2522.
22. Lee, M. J., Maliakal, P., Chen, L., Meng, X. et al., Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability. Cancer Epidemiol. Biomarkers Prev. 2002, 11, 1025-1032.
23. Andriamanalijaona, R., Kypriotou, M., Bauge, C., Renard, E. et al., Comparative effects of 2 antioxidants, selenomethionine and epigallocatechin-gallate, on catabolic and anabolic gene expression of articular chondrocytes. J. Rheumatol. 2005, 32, 1958-1967.
24. Chyu, K. Y., Babbidge, S. M., Zhao, X., Dandillaya, R. et al., Differential effects of green tea-derived catechin on developing versus established atherosclerosis in apolipoprotein E-null mice. Circulation 2004, 109, 2448-2453.
25. Gerszten, R. E., Garcia-Zepeda, E. A., Lim, Y. C., Yoshida, M. et al., MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature 1999, 398, 718-723.
26. Huo, Y., Weber, C., Forlow, S. B., Sperandio, M. et al., The chemokine KC, but not monocyte chemoattractant protein-1, triggers monocyte arrest on early atherosclerotic endothelium. J. Clin. Invest. 2001, 108, 1307-1314.
27. Martin, J., Collot-Teixeira, S., McGregor, L., McGregor, J. L., The dialogue between endothelial cells and monocytes/macrophages in vascular syndromes. Curr. Pharm. Des. 2007, 13, 1751-1759.
28. Otsuki, M., Hashimoto, K., Morimoto, Y., Kishimoto, T. et al., Circulating vascular cell adhesion molecule-1 (VCAM-1) in atherosclerotic NIDDM patients. Diabetes 1997, 46, 2096-2101.
29. Golias, C., Tsoutsi, E., Matziridis, A., Makridis, P. et al., Review. Leukocyte and endothelial cell adhesion molecules in inflammation focusing on inflammatory heart disease. In Vivo 2007, 21, 757-769.
30. Bartchewsky, W., Jr., Martini, M. R., Masiero, M., Squassoni, A. C. et al., Effect of Helicobacter pylori infection on IL-8, IL-1beta and COX-2 expression in patients with chronic gastritis and gastric cancer. Scand. J. Gastroenterol. 2009, 44, 153-161.
31. Brand, K., Page, S., Rogler, G., Bartsch, A. et al., Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. J. Clin. Invest 1996, 97, 1715-1722.
32. Bierhaus, A., Schiekofer, S., Schwaninger, M., Andrassy, M. et al., Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB. Diabetes 2001, 50, 2792-2808.
33. Sowers, J. R., Epstein, M., Frohlich, E. D., Diabetes, hypertension, and cardiovascular disease: an update. Hypertension 2001, 37, 1053-1059.
34. Wolfram, S., Raederstorff, D., Preller, M., Wang, Y. et al., Epigallocatechin gallate supplementation alleviates diabetes in rodents. J. Nutr. 2006, 136, 2512-2518.
35. Lambert, J. D., Hong, J., Kim, D. H., Mishin, V. M. et al., Piperine enhances the bioavailability of the tea polyphenol (-)-epigallocatechin-3-gallate in mice. J. Nutr. 2004, 134, 1948-1952.